Human brain endothelial cell-derived COX-2 facilitates extravasation of breast cancer cells across the blood-brain barrier

Anticancer Research

Volumn 31, Issue 12, 2011, Pages 4307-4313

  Lee, Kyue Yim ^a   Kim, Youn Jae ^a,b   Yoo, Heon ^a   Lee, Seung Hoon ^a   Park, Jong Bae ^a   Kim, Ho Jin ^a  

^a National Cancer Center   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Blood brain barrier; Brain endothelial cells; COX 2; Extravasation; Metastasis

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; GELATINASE A;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN ENDOTHELIUM CELL; BREAST CANCER; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM METASTASIS; RNA, SMALL INTERFERING; SOLUBILITY;

EID: 84855180754     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lu X and Kang Y: Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia 12: 153-162, 2007. (Pubitemid 47215433)
2. Weil RJ, Palmieri DC, Bronder JL, Stark AM and Steeg PS: Breast cancer metastasis to the central nervous system. Am J Pathol 167: 913-920, 2005. (Pubitemid 41416243)
3. Cheng X and Hung MC: Breast cancer brain metastases. Cancer Metastasis Rev 26: 635-643, 2007. (Pubitemid 350115113)
4. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
5. Nguyen DX, Bos PD and Massague J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284, 2009.
6. Kim HJ, Biernacki K, Prat A, Antel JP and Bar-Or A: Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T-cells generated in treated multiple sclerosis patients. Clin Immunol 111: 38-46, 2004. (Pubitemid 38482080)
7. Kim MS, Kwak HJ, Ue JW, Kim HJ, Park MJ, Park JB, Choi KH, Yoo H, Shin SH, Shin WS, Song ES and Lee SH: 17-Allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion. Mol Cancer Res 6: 1657-1665, 2008.
8. Casos K, Siguero L, Fernandez-Figueras MT, Leon X, Sarda MP, Vila L and Camacho M: Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation. Microvasc Res 81: 261-268, 2011.
9. Wang D and Dubois RN: Eicosanoids and cancer. Nat Rev Cancer 10: 181-193, 2010.
10. Wang MT, Honn KV and Nie D: Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534, 2007. (Pubitemid 350115125)
11. Ghosh N, Chaki R, Mandai V and Mandai SC: COX-2 as a target for cancer chemotherapy. Pharmacol Rep 62: 233-244, 2010.
12. Stasinopoulos I, O'Brien DR, Wildes F, Glunde K and Bhujwalla ZM: Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Mol Cancer Res 5: 435-442, 2007. (Pubitemid 46903952)
13. Singh B, Berry JA, Shoher A, Ayers GD, Wei C and Lucci A: COX-2 involvement in breast cancer metastasis to bone. Oncogene 26: 3789-3796, 2007. (Pubitemid 46878131)
14. Ito H, Duxbury M, Benoit E, Farivar RS, Gardner-Thorpe J, Zinner MJ, Ashley SW and Whang EE: Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. Biochem Biophys Res Commun 318: 594-600, 2004. (Pubitemid 38553820)
15. Takahashi Y, Kawahara F, Noguchi M, Miwa K, Sato H, Seiki M, Inoue H, Tanabe T and Yoshimoto T: Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2. FEBS Lett 460: 145-148, 1999. (Pubitemid 29479260)
16. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR and Begley DJ: Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25, 2010.
17. Lee BC, Lee TH, Avraham S and Avraham HK: Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2: 327-338, 2004. (Pubitemid 39025295)
18. Lee TH, Avraham HK, Jiang S and Avraham S: Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J Biol Chem 278: 5277-5284, 2003. (Pubitemid 36801042)
19. Singh-Ranger G, Salhab M and Mokbel K: The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res Treat 109: 189-198, 2008.
20. Howe LR: Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res 9: 210, 2007.
21. Fulton AM, Ma X and Kundu N: Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 66: 9794-9797, 2006. (Pubitemid 44672027)
22. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, AndersonGd, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY and Isakson PC: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoro-methyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem 40: 1347-1365, 1997.
23. Riemsma R, Forbes CA, Kessels A, Lykopoulos K, Amonkar MM, Rea DW and Kleijnen J: Systematic review of aromatase inhibitors in the first-line treatment for hormone-sensitive advanced or metastatic breast cancer. Breast Cancer Res Treat 123: 9-24, 2010.
24. Falandry C, Canney PA, Freyer G and Dirix LY: Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer. Ann Oncol 20: 615-620, 2009.
25. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997. (Pubitemid 27157312)
26. Bjorklund M and Koivunen E: Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69, 2005. (Pubitemid 40720240)
27. Nguyen M, Arkell J and Jackson CJ: Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33: 960-970, 2001. (Pubitemid 32706688)
28. Kargozaran H, Yuan SY, Breslin JW, Watson KD, Gaudreault N, Breen A and Wu MH: A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis 24: 495-502, 2007. (Pubitemid 47524807)
29. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD and Mansel RE: Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17: 583-590, 2006.
30. Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, Seiki M and Thompson EW: MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15: 111-120, 1997. (Pubitemid 27157813)